12,698views
00:00 / 00:00
Eyes, ears, nose and throat
Color blindness
Cortical blindness
Hemianopsia
Homonymous hemianopsia
Bitemporal hemianopsia
Cataract
Glaucoma
Retinal detachment
Age-related macular degeneration
Diabetic retinopathy
Corneal ulcer
Retinoblastoma
Retinopathy of prematurity
Periorbital cellulitis
Uveitis
Keratitis
Orbital cellulitis
Hordeolum (stye)
Conjunctivitis
Neonatal conjunctivitis
Conductive hearing loss
Eustachian tube dysfunction
Tympanic membrane perforation
Otitis externa
Otitis media
Vertigo
Meniere disease
Labyrinthitis
Acoustic neuroma (schwannoma)
Choanal atresia
Allergic rhinitis
Nasal polyps
Nasopharyngeal carcinoma
Sialadenitis
Parotitis
Ludwig angina
Aphthous ulcers
Temporomandibular joint dysfunction
Oral cancer
Warthin tumor
Sleep apnea
Gastroesophageal reflux disease (GERD)
Zenker diverticulum
Retropharyngeal and peritonsillar abscesses
Esophageal cancer
Laryngomalacia
Laryngitis
Bacterial epiglottitis
Thyroglossal duct cyst
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Vertigo: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Esophageal cancer
0 / 9 complete
0 / 3 complete
of complete
of complete
Laboratory value | Result |
CBC, Serum | |
Hemoglobin | 11.2 g/dL |
Hematocrit | 33.6% |
Leukocyte count | 10,100 /mm3 |
Platelet count | 149,000/mm3 |
MCV | 72 fL |
RDW | 11.5-14.5% |
Iron Studies, Serum | |
Serum Iron | 90 μg/dL |
Ferritin | Ferritin 170 ng/mL |
Total iron binding capacity | 220 μg/dL |
2022
2021
2020
2019
2018
2017
2016
esophageal cancer and p. 387
esophageal cancer p. 387
achalasia and p. 385
esophageal cancer and p. 387
esophageal cancer and p. 387
esophageal cancer and p. 387
esophageal cancer p. 387
Victoria S. Recalde, MD
Kaitlyn Harper, MS
Eric Karpie
Marisa Pedron
Robyn Hughes, MScBMC
Esophageal cancer is when malignant or cancerous cells arise in the esophagus. This cancer can appear in any segment of the esophagus and it’s further classified into squamous cell carcinoma and adenocarcinoma - depending on the type of cells it originates from. Squamous cell carcinoma, as you can tell by its name, arises from squamous epithelium. On the other hand, adeno- means gland. So, adenocarcinoma arises from columnar glandular epithelium. Esophageal cancer is generally considered a poor prognosis cancer, because it doesn't cause symptoms until later stages.
The esophagus is a long tube going from the pharynx to the stomach, and it’s connected to the pharynx through the upper esophageal sphincter, and to the stomach through the lower esophageal sphincter. Both relax during swallowing to allow the passage of food or liquids. Additionally, the lower esophageal sphincter is tightly closed between meals to prevent acid reflux. Now, the esophageal wall has four layers - from the outside in, these are the adventitia ; the muscular layer; the submucosa and the mucosa. The mucosa comes into direct contact with food, and it protects the esophageal wall from friction. The mucosa also has three layers of its own: a layer made of stratified squamous epithelium; a layer of connective tissue, called the lamina propria; and a layer of muscle cells, called the muscularis mucosae. Finally, at the lower esophageal sphincter, the squamous epithelium joins the columnar gastric epithelium to form the gastroesophageal junction.
Now, squamous cell carcinoma is the most common type of esophageal cancer worldwide, and it originates in the squamous epithelium of the esophagus, most often in the upper two thirds. When this epithelium is repeatedly exposed to risk factors like alcohol, cigarette smoke, or hot fluids, it gets damaged, so the squamous cells divide to replace the old damaged cells. With each division, there is a risk that a mutation can occur in the genes that are in charge of the cell cycle and cell division. Mutations can occur in tumor suppressor genes, which normally code for proteins that stop the cell cycle or promote apoptosis - so they’re the cell cycle’s very own brake pedal. Or they can occur in proto-oncogenes, which normally code for proteins that promote the cell cycle - so they’re the cell cycle’s accelerator pedal. When this happens, squamous cells start dividing uncontrollably, and more mutations accumulate with each division. So eventually, these mutations might make the cells malignant - meaning they gain the ability to invade neighboring tissues and spread to distant sites.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.